2295 participants
DESTINY Breast Respond HER2-(Ultra)Low Europe
- Study Type:
- OBSERVATIONAL
- Last Updated:
- 2026-08-19
- Start Date:
- 2023-10-24
- Completion:
- 2030-12-31
Conditions
- Unresectable Breast Cancer
- Metastatic Breast Cancer
- HER2-low Expressing Breast Cancer
- HER2-(Ultra)Low Expressing Breast Cancer
Interventions
- DRUG
No Results Yet